Back to results
US 2016/0002608 A1Published application
Methods to produce bunyavirus replicon particles
AssigneeStichting Dienst Landbouwkundig Onderzoek
InventorsJeroen Alexander Kortekaas, Robertus Jacobus Maria Moormann
Life of this patent
Estimating the term…
Abstract
The invention relates to methods of producing infectious bunyavirus replicon particles. These bunyavirus replicon particles are safe and can be used outside a biosafety containment. The invention further relates to recombinant bunyavirus replicon particles and uses of these recombinant bunyavirus replicon particles.
Claims12
1-9. (canceled)
A non-spreading recombinant bunyavirus replicon particle, comprising:
- a bunyavirus L genome segment
- a bunyavirus S genome segment or part of a bunyavirus S genome segment comprising at least the N gene and the 3′ and 5′ UTRs;
- and, optionally, when a bunyavirus M genome segment is to be present,
- a bunyavirus M genome segment from which the GnGc coding region has been functionally inactivated.
1 more element
13-15. (canceled)
A vaccine comprising the recombinant bunyavirus replicon particle according to claim 1.
Dependencies are inferred from the claim text.